MedPath

A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil

Phase 2
Terminated
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo
Registration Number
NCT00672945
Lead Sponsor
Epix Pharmaceuticals, Inc.
Brief Summary

A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 in subjects with Alzheimer's Disease receiving a stable dose of donepezil. The study consists of a 26-week double-blind treatment period.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
420
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PRX-03140PRX-03140-
PlaceboPlacebo-
Primary Outcome Measures
NameTimeMethod
Alzheimer's Disease Assessment Scale-Cognitive subscale.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (38)

Bradenton Research Center

🇺🇸

Bradenton, Florida, United States

Berma Research Group

🇺🇸

Plantation, Florida, United States

Maine Neurology

🇺🇸

Scarborough, Maine, United States

Behavioral Medical Research of Staten Island

🇺🇸

Staten Island, New York, United States

Todd Swick, MD, PA

🇺🇸

Houston, Texas, United States

Barrow Neurological Institute

🇺🇸

Phoenix, Arizona, United States

Global Medical Institutes

🇺🇸

Princeton, New Jersey, United States

University of Vermont

🇺🇸

Burlington, Vermont, United States

PsyPharma Clinical Research, Inc.

🇺🇸

Phoenix, Arizona, United States

Synergy Clinical Research Center

🇺🇸

National City, California, United States

Pacific Neuroscience Medical Group

🇺🇸

Oxnard, California, United States

California Neuroscience Research Medical Group, Inc.

🇺🇸

Sherman Oaks, California, United States

Brain Matters Research

🇺🇸

Delray Beach, Florida, United States

Renstar Medical Research

🇺🇸

Ocala, Florida, United States

Compass Research

🇺🇸

Orlando, Florida, United States

Clinical Neuroscience Solutions, Inc.

🇺🇸

Jacksonville, Florida, United States

Meridien Research

🇺🇸

St. Petersburg, Florida, United States

Roskamp Institute

🇺🇸

Tampa, Florida, United States

Stedman Clinical Trials

🇺🇸

Tampa, Florida, United States

Alexian Brothers Neroscience Institute

🇺🇸

Elk Grove Village, Illinois, United States

Four Rivers Clinical Research

🇺🇸

Paducah, Kentucky, United States

J. Gary Booker, MD

🇺🇸

Shreveport, Louisiana, United States

The ICPS Group

🇺🇸

Norwood, Massachusetts, United States

Memory Center of America

🇺🇸

Long Beach, New Jersey, United States

Neurological Associates of Albany, P.C.

🇺🇸

Albany, New York, United States

Alzheimer's Research Corporation

🇺🇸

Manchester, New Jersey, United States

The Mount Sinai Medical Center

🇺🇸

New York, New York, United States

Neurology and Neuroscience Center of Ohio

🇺🇸

Toledo, Ohio, United States

RI Mood and Memory Research Institute

🇺🇸

East Providence, Rhode Island, United States

The Neurological Institute, P.A.

🇺🇸

Charlotte, North Carolina, United States

MedArk

🇺🇸

Morgantown, North Carolina, United States

The Memory Clinic

🇺🇸

Bennington, Vermont, United States

The Center for Excellence in Aging and Geriatric Health

🇺🇸

Williamsburg, Virginia, United States

The Glennan Center for Geriatrics & Gerontology, Eastern Virginia Medical School

🇺🇸

Norfolk, Virginia, United States

Torrance Clinical Research

🇺🇸

Torrance, California, United States

Social Psychiatry Research Institute

🇺🇸

Brooklyn, New York, United States

Tulsa Clinical Research, LLC

🇺🇸

Tulsa, Oklahoma, United States

Northwest NeuroSpecialists, PLLC

🇺🇸

Tucson, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath